Véronique Lecault
Founder bei ABCELLERA BIOLOGICS INC.
Vermögen: 43 Mio $ am 31.03.2024
Profil
Dr. Vronique Lecault ist Vice President bei Lineage Biosciences, Inc. und Chief Operating Officer & Director bei AbCellera Biologics, Inc. Sie ist Mitglied des Board of Directors bei Trianni, Inc. und Channel Biologics Pty Ltd. sowie bei AbCellera Biologics, Inc. Sie erhielt ihren Bachelor-Abschluss von der University of Ottawa und einen Doktortitel von der University of British Columbia.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.01.2024 | 9 530 340 ( 3,26% ) | 43 Mio $ | 31.03.2024 |
Aktive Positionen von Véronique Lecault
| Unternehmen | Position | Beginn |
|---|---|---|
| ABCELLERA BIOLOGICS INC. | Founder | 08.11.2012 |
Lineage Biosciences, Inc.
 Lineage Biosciences, Inc. Hospital/Nursing ManagementHealth Services Lineage Biosciences, Inc. engages in biotechnology services. The company was founded on May 30, 2014 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | 01.01.2018 |
| AbCellera Australia Pty Ltd. | Director/Board Member | 01.09.2019 |
Trianni, Inc.
 Trianni, Inc. BiotechnologyHealth Technology TRIANNI, Inc. operates as a biotech company. It specializes in antibody discovery technology using transgenic mice. Its Trianni Mouse platform enables the generation of fully-human monoclonal antibodies. The company was founded in 2010 and is headquartered in San Francisco, CA. | Director/Board Member | 01.11.2020 |
Ausbildung von Véronique Lecault
| University of British Columbia | Doctorate Degree |
| University of Ottawa | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ABCELLERA BIOLOGICS INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Trianni, Inc.
Trianni, Inc. BiotechnologyHealth Technology TRIANNI, Inc. operates as a biotech company. It specializes in antibody discovery technology using transgenic mice. Its Trianni Mouse platform enables the generation of fully-human monoclonal antibodies. The company was founded in 2010 and is headquartered in San Francisco, CA. | Health Technology |
Lineage Biosciences, Inc.
Lineage Biosciences, Inc. Hospital/Nursing ManagementHealth Services Lineage Biosciences, Inc. engages in biotechnology services. The company was founded on May 30, 2014 and is headquartered in Vancouver, Canada. | Health Services |
| AbCellera Australia Pty Ltd. |
